FINWIRES · TerminalLIVE
FINWIRES

UBS Upgrades Edwards Lifesciences to Buy From Neutral, Adjusts Price Target to $110 From $90

By

Edwards Lifesciences (EW) has an average rating of overweight and mean price target of $102.02, according to analysts polled by FactSet.

Price: $85.23, Change: $+2.19, Percent Change: +2.64%

What else is happening in Research?